Introduction
Infectious keratitis is a potentially sight-threatening condition which can be caused by bacteria, virus, fungus, or parasites. In China, there are 3 million corneal blind patients with an annual increase rate of 100,000 cases. 1 In India, 2 million people suffer a corneal ulcer every year. 2 In the United States, the Center for Disease Control (CDC) has reported an incidence of 71,000 patients having infectious keratitis per year, and infectious keratitis has become the most widespread complication of contact lens use. 3, 4 In infectious keratitis, bacteria are the most common infectious agents, in particular Gram-positive cocci, such as Staphylococcus epidermidis and Staphylococcus aureus. 5 Considering the rapid progression and severe complications induced by bacterial keratitis, empiric broad-spectrum antibiotic therapy should be started promptly and most cases of bacterial keratitis are treated effectively with topical antibiotic eye drops. However, recent studies have shown the increasing incidence of antibiotic-resistant bacterial infections. 2, 6 In the United States, 80% of ocular isolates of methicillin-resistant S. aureus were resistant to the commonly prescribed antibiotics. 3, 7 In addition, the localization of microorganisms within deep corneal structure makes antibacterial eye drops less effective and requires multiple instillations or increased concentrations with ocular surface toxicity issues. 8 Therefore, it is important to find other effective adjuvant therapies for the management of bacterial keratitis.
Photodynamic therapy (PDT) is a process that combines photosensitizers (PS) and light irradiation to produce reactive oxygens species (ROS) that will oxidize biologic components and lead to cell death. 9, 10 After its initial use for tumor treatment, photodynamic antimicrobial chemotherapy (PACT) has been shown to be effective for the elimination of microorganisms. 11 PACT can inactivate or kill a wide range of microbial pathogens, 12 especially antibiotic-resistant microbial pathogens, such as vancomycin-resistant Enterococcus species, methicillin-resistant S. aureus and multidrug-resistant Mycobacterium tuberculosis. [13] [14] [15] [16] [17] To date, the main PACT strategy against infectious keratitis is based on the application of riboflavin (RFV, vitamin B 2 ) with ultraviolet light A (UVA) irradiation at 365 nm. 18, 19 However, its moderate antimicrobial effect limited its clinical application for the treatment of infectious keratitis.
Toluidine blue O (TBO), another hydrophilic cationic PS, is considered an effective membranedestroying photosensitizing agent with a good interaction and high affinity to bacterial membranes in vitro. Compared to the antimicrobial effect of RFVmediated UVA, the PACT effect of TBO and red light may be much stronger. 20, 21 The lower ROS production from RFV compared to the use of TBO could explain these results. TBO has become one of the PSs used clinically for antimicrobial treatments, especially in the field of dentistry. 22, 23 For ocular infection, PACT with TBO treatment has been evaluated only in vitro for fungal and Acanthamoeba keratitis. 24, 25 To our knowledge, no research has focused on its effectiveness against ocular bacterial infection. Therefore, we determined whether TBO-mediated PDT could affect the bioactivity of S. epidermis and S. aureus in vitro.
Materials and Methods

Bacteria Isolation and Culture
Twenty-four strains of bacteria (12 isolates of S. epidermidis and 12 of S. aureus) were selected for this study. All bacterial strains were isolated from patients with bacterial keratitis provided by the department of microbiology, Beijing Institute of Ophthalmology, Beijing Tongren Hospital. The bacterial strains stored in a glycerol tube were revived and inoculated on blood agar (Jinzhang Technique Development Co., Tianjin, China) at 36.58C for 48 hours; then bacterial colonies were scraped with an inoculation loop and 0.5 McFarland bacterial suspensions (concentration, 1~2 3 10 8 colony-forming units [CFU]/mL) were prepared.
Light Source and Photosensitizer
The experimental setup, including the light system and 96-well microtiter plates, is shown in Figure 1 .
The light system consisted of a high-power lightemitting diode (LED) array and a power supply. The wavelength of the LED array was centered at 625 nm and its bandwidth was 20 nm. The LED light source was fed by a small direct current (DC) power supply (MCH-K305D; MCH Instruments Co., Ltd., Shenzhen, China). The size of the LED array was able to cover part of the 96-well plate with an adjustable power intensity. The light power output was measured with an optical power meter (VLP-2000; Femtosecond Technology Co., Ltd., Changchun, China).
The photosensitizer used in this study was TBO (Sigma-Aldrich Technology Co., Ltd., St. Louis, MO). The TBO solution was prepared at a concentration of 1 mM with distilled water. After sterilization by passage through 0.22-lm pore size membrane filters, the TBO solution was stored at 48C in the dark until experimental use.
The Effect of PS Concentration and Light Irradiation Intensity
The effect of PS concentration on S. epidermidis and S. aureus was studied. Bacterial suspensions (1 3 10 8 CFU/mL) were incubated with a gradient in the TBO concentration (20, 40, 60 , and 80 lM) in 96-well microtiter tissue culture plates. The control wells were incubated with PBS. The population density of the experimental bacterial samples was maintained at approximately 1 3 10 7 CFU/mL. All culture plates were kept in the dark at room temperature for 20 minutes. After incubation, irradiation was performed with red light (irradiance, 7.30 mW/cm 2 ) for 30 minutes and the fluency level was 13.14 J/cm 2 .
The bacterial survival fraction (antimicrobial effect parameters) with different TBO concentrations was calculated and the optimal TBO concentration was obtained. Bacterial survival after treatment was assessed using the colony counting and colony survival fraction (SF) method. 26 After experimental treatments, 100-lL aliquots were withdrawn from each well and serially diluted 10-fold with PBS. Then, a 10-lL mixture dilution from each well was inoculated onto blood agar plates in triplicate. After an incubation of 48 hours at 378C, bacterial colonies were counted. The survival fractions of bacteria were determined with the equation N/N 0 , where N 0 is the number of bacterial colonies before treatment (CFUs per mL of bacteria) and N is the number of bacterial colonies after light and PS treatment.
After determining the appropriate TBO concentration, the effect of different light irradiation intensities was also studied. All bacterial strains were incubated with TBO concentration solution for 20 minutes. Then, illumination was performed with red light for 20 minutes at various light power intensities (0.68, 1.07, 2.47, 5.27, and 7.30 mW/cm 2 ). All experiments were performed with a control group kept in the dark as described above. With these tests and the analysis of survival fractions of bacteria, the appropriate irradiance of red light was determined. Following the same method, 24 strains of bacteria were exposed to red light at the optimum power intensity (based on the above results) for 5, 10, 20, 30, or 40 minutes. Eventually, the best irradiation duration was determined similarly with the calculation of survival fractions after treatment.
PACT with TBO and Red Light
Based on the above results on optimal TBO concentration, irradiation intensity, and duration, the effect of PACT with TBO and red light was investigated. Bacterial suspensions (150 lL; isolates of S. epidermidis and S. aureus) were incubated with TBO solution in the dark at room temperature for 20 minutes and placed in 96-well microtiter plates (height of bacterial suspension was 3.6 mm). The bacterial cell density of the experimental samples was maintained at 1 3 10 7 CFU/mL and the TBO concentration was kept at the optimal level mentioned above. After incubation, four experimental groups were established as follows: Group 1, TBO alone (TþLÀ); wells containing TBO were kept in the dark without red light exposure. Group 2, LED irradiation alone (TÀLþ), suspensions with PBS were exposed to the optimal intensity of red light. Group 3, TBO-LED irradiation combination (TþLþ), the TBO-containing wells were exposed to red light with the optimal TBO concentration, light irradiance, and irradiation time. Group 4, within the control group (TÀLÀ) suspensions with PBS were kept in the dark. After experimental procedures, 100 lL of bacterial suspensions were inoculated on blood agar plates at 378C for 48 hours and bacterial colonies were counted. The survival fractions (N/N 0 ) of bacteria were determined.
Statistical Analysis
All results were presented as mean 6 standard deviation (SD). Statistical analyses were performed using SPSS software (version 18.0; SPSS, Inc., Chicago, IL). The normal distribution of the results was tested using the Kolmogorov-Smirnov test. Descriptive statistics were used to summarize the data in multiplex analyses. The statistical significance between groups was determined using 2-way analysis of variance. P , 0.05 was considered statistically significant.
Results
The Antibacterial Effect of Different PS Concentrations
As the TBO concentration increased, the survival fraction of S. epidermidis showed a declining trend ( Fig. 2A) . The difference in the survival fraction among different TBO concentrations was significant (F ¼ 3.534, P , 0.001, Table 1 ). The antibacterial efficacy of PACT increased as the TBO concentration increased from 20 to 60 lM and then was stable from 60 to 80 lM (t ¼ 1.524, P ¼ 0.139, Table 1 ). With regard to S. aureus (Fig. 3A) , a similar significant difference in survival fraction also was noted between the control and PACT groups at all tested concentrations of TBO (F ¼ 5.392, P , 0.001, Table 1 ). The survival fraction decreased as the concentration of TBO increased, at a constant red light irradiation (13.14 J/cm 2 ). In the S. epidermidis and S. aureus groups, the antibacterial efficacy also was stable with the TBO concentrations higher than 60 lM (P ¼ 0.139, 0.318, Table 1 ). Consequently, the antibacterial efficacy of PACT was TBO concentration-dependent up to 60 lM. Therefore, this concentration was used in the further experiments.
Effect of Light Irradiation Intensity and Duration
The bacterial survival fractions treated with 60 lm TBO at different light irradiation intensities are presented in Figures 2B and 3B . The survival of S. epidermidis and S. aureus decreased gradually as light irradiation intensities increased (F ¼ 2.514, P ¼ 0.006; F ¼ 2.963, P ¼ 0.002, respectively; Table 2 ). The survival fraction at light irradiation of 5.27 and 7.30 mW/cm 2 was not significantly different in the S. epidermidis and S. aureus groups (P ¼ 0.056, 0.062, respectively). Consequently, the light irradiation intensity used in the further experiments was 5.27 mW/cm 2 . Meanwhile, at a given light irradiation intensity, a greater decrease was observed for S. epidermidis. For example, at a lower light irradiation (0.68 mW/cm 2 ), the cell survival of S. epidermidis (0.138 6 0.043) was almost four times lower than that of S. aureus (0.510 6 0.048). This difference was significant (t ¼ 2.421, P ¼ 0.025). When the light irradiance was kept at 5.27 mW/ cm 2 and the TBO concentration was 60 lM, the survival fractions of S. epidermidis and S. aureus exposed to red light for 5, 10, 20, 30, and 40 minutes were measured (Table 3 ) and plotted in Figures 2C  and 3C , respectively. With 5 minutes of light irradiation, the survival fraction of S. epidermidis and S. aureus decreased to nearly 70% (0.274 6 0.073) and 50% (0.466 6 0.052), respectively. These results indicated that the antibacterial efficacy mainly occurred in the initial phase of illumination. Over 30 minutes, the differences in the survival fraction between every two time points were significant (P ¼ 0.001~0.004 in the S. epidermidis group and P ¼ 0.001~0.005 in the S. aureus group). Comparing the survival fraction at 40 and 30 minutes, the differences were not significant in these two groups (P ¼ 0.083 and P ¼ 0.261, respectively). Consequently, the light irradiation time selected for further experiments was 30 minutes.
PACT with TBO and Red Light
With the above-determined PACT parameters (irradiance, 5.27 mW/cm 2 ; irradiation time, 30 minutes; TBO concentration, 60 lM), the effect of TBOmediated PDT on the ocular pathogenic bacteria was evaluated. In group 1, the treatment of 60-lM TBO in the dark environment did not provide any antibacterial efficacy to S. epidermidis (1.48E7 6 1.5E6 CFU/ mL) and S. aureus (1.45E7 6 9E5 CFU/mL). Compared to the bacterial cell density (1 3 10 7 CFU/mL) of experimental samples before treatment, the differences were not significant (both P . 0.05). Similarly, in group 2, light with 5.27 mW/cm 2 alone did not cause any change in bacteria growth density (S. epidermidis, 1.49E7 6 1.43E6; S. aureus, 1.5E7 6 
Discussion
PACT is a photochemical reaction process in which microorganisms are treated with cytotoxic ROS produced by a photosensitizing agent irradiated with low-intensity visible light. 27 We investigated the effect of the photodynamic action of TBO on the viability of S. epidermidis and S. aureus isolated from ocular surface infections.
Our results showed that a large number of S. epidermidis and S. aureus cells could be inactivated when they were irradiated using a LED light with the presence of TBO. These results were similar to those observed by Halili et al. 14 study gave us good tips to get the accurate antibacterial effect. TBO is another photosensitizer considered to have higher antimicrobial effect than riboflavin. [20] [21] However, it has been previously evaluated in vitro only for fungal and Acanthamoeba isolates. [24] [25] Interestingly, the survival fraction of bacteria suspensions decreased as the concentration of TBO increased, when the dose of light irradiation was constant. Meanwhile, as the irradiance intensity or irradiation time increased, the survival of S. epidermidis and S. aureus decreased gradually. We also observed that the antibacterial effect mainly occurred in the initial phase of irradiation. As free oxygen in the solution is depleted by the photodynamic process with singlet oxygen and ROS generation, photodynamic effect became less effective with time and reaching a plateau.
Photo-damage to the DNA and the cytoplasmic membrane has been proposed as possible mechanisms of PDT in bacteria. 22 An in vitro study using hematoporphyrin-PACT against S. aureus demonstrated that PACT resulted in photo damage to cytoplasmic membrane proteins as well as chromosomal and plasmid DNA. 28 Furthermore, PACT also may induce oxidative stress-derived DNA damage and lead to the production of 7, 8-dihydro-8-oxo-20deoxyguanosine (8-oxodG) . 29 This modification of guanidine could cause DNA mis-replication and fragmentation. 30 These results also revealed that the photosensitivity of S. epidermidis was higher than that of S. aureus when they were irradiated under similar conditions, and this difference was more significant at lower light doses. Gad et al. 31 reported a higher photo-killing effect on S. epidermidis than on S. aureus using methylene blue as photosensitizer, which is similar to TBO. Abundant production of polysaccharide from S. epidermidis has been suggested to obstruct the diffusion of the photosensitizer through the extracellular polymer matrix; 32 thus, reducing the susceptibility to photosensitization. Another reason could be the intrinsic variation of S. aureus, especially the thickness of its cell wall, which may result in the S. aureus cells appearing more resistant to photo-killing, such as intrinsic variation in the cell wall thickness influencing the dye uptake. 32 Hence, to achieve the same antimicrobial efficacy, a higher light dosage or higher TBO concentration could be required.
Research has shown promising capabilities of PACT. There are several advantages of PACT over conventional antimicrobial agents. First, rapid killing of the target organism mainly depends on the light irradiation dose delivered and appropriate PS con-centration. Second, resistance development would be unlikely, since killing is mediated by singlet oxygen and free radicals, and high concentrations of photosensitizer do not need to be maintained at the disease site for more than a few minutes, in contrast to the hours or even days necessary in the case of conventional antimicrobial agents. Finally, antimicrobial effects can be confined to the site of the lesion by careful topical application of photosensitizer and the area of irradiation can be restricted further by using an optical fiber. 33 However, the safety of PACT for ocular surface infection should be evaluated further before clinical application. Meanwhile, its clinical applicability and feasibility also should be considered, although the antimicrobial effect of PACT in vitro was obvious.
In conclusion, this study demonstrated that common pathogens of the ocular surface could be effectively inactivated by TBO-mediated PACT. The antimicrobial effect of PACT was related to PS concentration and light dosage. Further insight into PACT with in vivo experiments is required to ensure the safety and effectiveness of PACT.
